Clinical trial Recruiting at 1 site Interventional Ages 15 and up

Evaluating chest tube size and daily lavage for traumatic hemothorax treatment

Official title: Traumatic Hemothorax Treatment With 14-Fr Pigtail Catheters or Large Bore (~28Fr) Chest Tubes With Daily Irrigation: A Pilot Single-Arm Intervention Study

Run by University of Pennsylvania · NCT06937450 · Data updated 2026-11-12

This study is testing whether using different sizes of chest tubes and daily washing can improve recovery for patients with bleeding in the chest after a trauma.

More Traumatic Brain Injury trials

Quick facts

Study typeInterventional
Ages15 Years and up
SexAll
Enrollment20 (estimated)
SponsorUniversity of Pennsylvania
Academic / other
Locations1 site (Philadelphia, Pennsylvania)
StatusRecruiting
StartedMarch 30, 2025
Main results expectedDecember 31, 2026
Study endsAugust 1, 2027
Registry record updatedSeptember 11, 2026
Trial IDNCT06937450 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are stable trauma patients over 15 years old with acute traumatic hemothorax requiring drainage.

Probably not a fit

Patients with hemothorax not requiring drainage or those undergoing immediate surgical intervention may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study investigates the impact of different chest tube sizes and the effects of daily irrigation on patients with acute traumatic hemothorax. A total of 20 stable trauma patients requiring chest tube drainage will be enrolled and assigned to receive either a 28Fr or 14Fr chest tube. Daily lavage will be performed at 24 and 48 hours post-placement, and outcomes will be compared to historical controls. The study aims to assess the need for additional interventions, complications, and patient-reported outcomes.

Why it matters

Potential benefit: If successful, this study could improve management strategies for traumatic hemothorax, potentially reducing complications and hospital stays.

How similar studies have gone: While similar approaches have been explored, this specific combination of chest tube size and daily lavage is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Able to provide consent for the research study
2. More than 15 years of age
3. Presence of acute traumatic HTX or HTX-PTX diagnosed on chest CT scan within 24 hours of injury and clinical indication for drainage (hemothorax of moderate or large size greater then 300 mL)
4. Hemodynamic stability (heart rate 120 beats per minute; systolic blood pressure 90 mmHg)
5. Bilateral or unilateral hemothorax of greater than 300 mL HTX by Mergo Formula from chest CT
6. Able to complete the entire study including randomization, tube placement, lavages and final CT Scan.

Exclusion Criteria:

1. Less than 15 years of Age
2. Prisoner
3. Pregnant due to the risk of CT scans
4. HTX or HTX-PTX not requiring drainage or drainage performed prior to randomization/enrollment
5. Patients undergoing operative intervention (i.e. thoracotomy) as initial management of hemothorax (6) Persistent hemodynamic instability after initial resuscitation and CT imaging

Where it's running

  • Penn Presbyterian Medical Center
    Philadelphia, Pennsylvania, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.